nodes	percent_of_prediction	percent_of_DWPC	metapath
Almotriptan—CYP2E1—Pilocarpine—glaucoma	0.097	0.156	CbGbCtD
Almotriptan—CYP2E1—Methazolamide—glaucoma	0.0655	0.105	CbGbCtD
Almotriptan—CYP2D6—Carteolol—glaucoma	0.061	0.0979	CbGbCtD
Almotriptan—CYP1A2—Betaxolol—glaucoma	0.05	0.0802	CbGbCtD
Almotriptan—CYP2D6—Betaxolol—glaucoma	0.0412	0.0661	CbGbCtD
Almotriptan—CYP2C19—Methazolamide—glaucoma	0.0411	0.0659	CbGbCtD
Almotriptan—CYP2C19—Timolol—glaucoma	0.0349	0.056	CbGbCtD
Almotriptan—CYP2D6—Methazolamide—glaucoma	0.0312	0.0501	CbGbCtD
Almotriptan—CYP3A4—Pilocarpine—glaucoma	0.0294	0.0472	CbGbCtD
Almotriptan—CYP1A2—Clonidine—glaucoma	0.0274	0.044	CbGbCtD
Almotriptan—CYP2D6—Timolol—glaucoma	0.0265	0.0426	CbGbCtD
Almotriptan—CYP3A4—Brinzolamide—glaucoma	0.0231	0.037	CbGbCtD
Almotriptan—CYP2D6—Clonidine—glaucoma	0.0226	0.0362	CbGbCtD
Almotriptan—CYP3A4—Dorzolamide—glaucoma	0.0223	0.0357	CbGbCtD
Almotriptan—CYP3A4—Methazolamide—glaucoma	0.0198	0.0319	CbGbCtD
Almotriptan—CYP3A4—Acetazolamide—glaucoma	0.0159	0.0255	CbGbCtD
Almotriptan—CYP3A4—Clonidine—glaucoma	0.0143	0.023	CbGbCtD
Almotriptan—Melatonin—CYP1B1—glaucoma	0.000855	1	CrCbGaD
Almotriptan—Somnolence—Brinzolamide—glaucoma	0.000246	0.000735	CcSEcCtD
Almotriptan—Vision blurred—Clonidine—glaucoma	0.000245	0.000732	CcSEcCtD
Almotriptan—Tremor—Clonidine—glaucoma	0.000244	0.000728	CcSEcCtD
Almotriptan—Dyspepsia—Brinzolamide—glaucoma	0.000244	0.000727	CcSEcCtD
Almotriptan—Eye disorder—Betaxolol—glaucoma	0.000243	0.000726	CcSEcCtD
Almotriptan—Pruritus—Apraclonidine—glaucoma	0.000243	0.000725	CcSEcCtD
Almotriptan—Body temperature increased—Acetazolamide—glaucoma	0.000243	0.000725	CcSEcCtD
Almotriptan—Fatigue—Dorzolamide—glaucoma	0.000243	0.000725	CcSEcCtD
Almotriptan—Tinnitus—Betaxolol—glaucoma	0.000243	0.000725	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000242	0.000724	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Travoprost—glaucoma	0.000242	0.000723	CcSEcCtD
Almotriptan—Fatigue—Travoprost—glaucoma	0.000242	0.000722	CcSEcCtD
Almotriptan—Cardiac disorder—Betaxolol—glaucoma	0.000242	0.000721	CcSEcCtD
Almotriptan—Ill-defined disorder—Clonidine—glaucoma	0.000242	0.000721	CcSEcCtD
Almotriptan—Pain—Dorzolamide—glaucoma	0.000241	0.000719	CcSEcCtD
Almotriptan—Insomnia—Pilocarpine—glaucoma	0.000241	0.000718	CcSEcCtD
Almotriptan—Pain—Travoprost—glaucoma	0.00024	0.000716	CcSEcCtD
Almotriptan—Hyperglycaemia—Timolol—glaucoma	0.00024	0.000716	CcSEcCtD
Almotriptan—Agitation—Clonidine—glaucoma	0.000239	0.000714	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000239	0.000713	CcSEcCtD
Almotriptan—Paraesthesia—Pilocarpine—glaucoma	0.000239	0.000713	CcSEcCtD
Almotriptan—Asthenia—Bimatoprost—glaucoma	0.000239	0.000713	CcSEcCtD
Almotriptan—Fatigue—Brinzolamide—glaucoma	0.000239	0.000713	CcSEcCtD
Almotriptan—Angioedema—Clonidine—glaucoma	0.000238	0.00071	CcSEcCtD
Almotriptan—Dyspnoea—Pilocarpine—glaucoma	0.000237	0.000708	CcSEcCtD
Almotriptan—Pain—Brinzolamide—glaucoma	0.000237	0.000707	CcSEcCtD
Almotriptan—Somnolence—Pilocarpine—glaucoma	0.000237	0.000706	CcSEcCtD
Almotriptan—Pruritus—Bimatoprost—glaucoma	0.000236	0.000703	CcSEcCtD
Almotriptan—Immune system disorder—Betaxolol—glaucoma	0.000235	0.000702	CcSEcCtD
Almotriptan—Diarrhoea—Apraclonidine—glaucoma	0.000235	0.000702	CcSEcCtD
Almotriptan—Malaise—Clonidine—glaucoma	0.000235	0.000701	CcSEcCtD
Almotriptan—Dyspepsia—Pilocarpine—glaucoma	0.000234	0.000699	CcSEcCtD
Almotriptan—Chills—Betaxolol—glaucoma	0.000234	0.000697	CcSEcCtD
Almotriptan—Syncope—Clonidine—glaucoma	0.000234	0.000697	CcSEcCtD
Almotriptan—Feeling abnormal—Dorzolamide—glaucoma	0.000232	0.000693	CcSEcCtD
Almotriptan—Feeling abnormal—Travoprost—glaucoma	0.000231	0.00069	CcSEcCtD
Almotriptan—Conjunctivitis—Timolol—glaucoma	0.00023	0.000688	CcSEcCtD
Almotriptan—Gastrointestinal pain—Dorzolamide—glaucoma	0.00023	0.000687	CcSEcCtD
Almotriptan—Palpitations—Clonidine—glaucoma	0.00023	0.000687	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Pilocarpine—glaucoma	0.00023	0.000686	CcSEcCtD
Almotriptan—Gastrointestinal pain—Travoprost—glaucoma	0.000229	0.000684	CcSEcCtD
Almotriptan—Loss of consciousness—Clonidine—glaucoma	0.000229	0.000683	CcSEcCtD
Almotriptan—Feeling abnormal—Brinzolamide—glaucoma	0.000228	0.000681	CcSEcCtD
Almotriptan—Mental disorder—Betaxolol—glaucoma	0.000228	0.000681	CcSEcCtD
Almotriptan—Pain—Pilocarpine—glaucoma	0.000228	0.000679	CcSEcCtD
Almotriptan—Dizziness—Apraclonidine—glaucoma	0.000227	0.000678	CcSEcCtD
Almotriptan—Erythema—Betaxolol—glaucoma	0.000227	0.000677	CcSEcCtD
Almotriptan—Epistaxis—Timolol—glaucoma	0.000224	0.000667	CcSEcCtD
Almotriptan—Body temperature increased—Dorzolamide—glaucoma	0.000223	0.000665	CcSEcCtD
Almotriptan—Abdominal pain—Dorzolamide—glaucoma	0.000223	0.000665	CcSEcCtD
Almotriptan—Tension—Betaxolol—glaucoma	0.000222	0.000664	CcSEcCtD
Almotriptan—Sinusitis—Timolol—glaucoma	0.000222	0.000664	CcSEcCtD
Almotriptan—Dysgeusia—Betaxolol—glaucoma	0.000222	0.000663	CcSEcCtD
Almotriptan—Chest pain—Clonidine—glaucoma	0.000222	0.000662	CcSEcCtD
Almotriptan—Arthralgia—Clonidine—glaucoma	0.000222	0.000662	CcSEcCtD
Almotriptan—Abdominal pain—Travoprost—glaucoma	0.000222	0.000662	CcSEcCtD
Almotriptan—Anxiety—Clonidine—glaucoma	0.000221	0.000659	CcSEcCtD
Almotriptan—Asthenia—Acetazolamide—glaucoma	0.00022	0.000658	CcSEcCtD
Almotriptan—Dizziness—Bimatoprost—glaucoma	0.00022	0.000657	CcSEcCtD
Almotriptan—Nervousness—Betaxolol—glaucoma	0.00022	0.000657	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.00022	0.000657	CcSEcCtD
Almotriptan—Feeling abnormal—Pilocarpine—glaucoma	0.000219	0.000655	CcSEcCtD
Almotriptan—Discomfort—Clonidine—glaucoma	0.000219	0.000654	CcSEcCtD
Almotriptan—Vomiting—Apraclonidine—glaucoma	0.000218	0.000652	CcSEcCtD
Almotriptan—Gastrointestinal pain—Pilocarpine—glaucoma	0.000218	0.00065	CcSEcCtD
Almotriptan—Hypersensitivity—Brimonidine—glaucoma	0.000217	0.000649	CcSEcCtD
Almotriptan—Dry mouth—Clonidine—glaucoma	0.000217	0.000647	CcSEcCtD
Almotriptan—Dermatitis—Apraclonidine—glaucoma	0.000216	0.000646	CcSEcCtD
Almotriptan—Headache—Apraclonidine—glaucoma	0.000215	0.000642	CcSEcCtD
Almotriptan—Confusional state—Clonidine—glaucoma	0.000214	0.00064	CcSEcCtD
Almotriptan—Vision blurred—Betaxolol—glaucoma	0.000214	0.000638	CcSEcCtD
Almotriptan—Rhinitis—Timolol—glaucoma	0.000213	0.000637	CcSEcCtD
Almotriptan—Tremor—Betaxolol—glaucoma	0.000212	0.000634	CcSEcCtD
Almotriptan—Asthenia—Brimonidine—glaucoma	0.000212	0.000632	CcSEcCtD
Almotriptan—Body temperature increased—Pilocarpine—glaucoma	0.00021	0.000628	CcSEcCtD
Almotriptan—Abdominal pain—Pilocarpine—glaucoma	0.00021	0.000628	CcSEcCtD
Almotriptan—Ill-defined disorder—Betaxolol—glaucoma	0.00021	0.000628	CcSEcCtD
Almotriptan—Diarrhoea—Acetazolamide—glaucoma	0.00021	0.000627	CcSEcCtD
Almotriptan—Rash—Bimatoprost—glaucoma	0.00021	0.000627	CcSEcCtD
Almotriptan—Dermatitis—Bimatoprost—glaucoma	0.00021	0.000626	CcSEcCtD
Almotriptan—Shock—Clonidine—glaucoma	0.000209	0.000624	CcSEcCtD
Almotriptan—Pruritus—Brimonidine—glaucoma	0.000209	0.000623	CcSEcCtD
Almotriptan—Headache—Bimatoprost—glaucoma	0.000209	0.000623	CcSEcCtD
Almotriptan—Nervous system disorder—Clonidine—glaucoma	0.000208	0.000622	CcSEcCtD
Almotriptan—Hypersensitivity—Dorzolamide—glaucoma	0.000207	0.000619	CcSEcCtD
Almotriptan—Tachycardia—Clonidine—glaucoma	0.000207	0.000619	CcSEcCtD
Almotriptan—Hypersensitivity—Travoprost—glaucoma	0.000207	0.000617	CcSEcCtD
Almotriptan—Skin disorder—Clonidine—glaucoma	0.000206	0.000616	CcSEcCtD
Almotriptan—Hyperhidrosis—Clonidine—glaucoma	0.000205	0.000613	CcSEcCtD
Almotriptan—Visual impairment—Timolol—glaucoma	0.000205	0.000612	CcSEcCtD
Almotriptan—Malaise—Betaxolol—glaucoma	0.000204	0.00061	CcSEcCtD
Almotriptan—Nausea—Apraclonidine—glaucoma	0.000204	0.000609	CcSEcCtD
Almotriptan—Hypersensitivity—Brinzolamide—glaucoma	0.000204	0.000609	CcSEcCtD
Almotriptan—Vertigo—Betaxolol—glaucoma	0.000204	0.000608	CcSEcCtD
Almotriptan—Syncope—Betaxolol—glaucoma	0.000203	0.000607	CcSEcCtD
Almotriptan—Dizziness—Acetazolamide—glaucoma	0.000203	0.000606	CcSEcCtD
Almotriptan—Asthenia—Dorzolamide—glaucoma	0.000202	0.000603	CcSEcCtD
Almotriptan—Asthenia—Travoprost—glaucoma	0.000201	0.000601	CcSEcCtD
Almotriptan—Palpitations—Betaxolol—glaucoma	0.0002	0.000598	CcSEcCtD
Almotriptan—Pruritus—Dorzolamide—glaucoma	0.000199	0.000595	CcSEcCtD
Almotriptan—Loss of consciousness—Betaxolol—glaucoma	0.000199	0.000595	CcSEcCtD
Almotriptan—Eye disorder—Timolol—glaucoma	0.000199	0.000593	CcSEcCtD
Almotriptan—Asthenia—Brinzolamide—glaucoma	0.000199	0.000593	CcSEcCtD
Almotriptan—Pruritus—Travoprost—glaucoma	0.000198	0.000592	CcSEcCtD
Almotriptan—Tinnitus—Timolol—glaucoma	0.000198	0.000592	CcSEcCtD
Almotriptan—Nausea—Bimatoprost—glaucoma	0.000198	0.00059	CcSEcCtD
Almotriptan—Cardiac disorder—Timolol—glaucoma	0.000197	0.000589	CcSEcCtD
Almotriptan—Hypersensitivity—Pilocarpine—glaucoma	0.000196	0.000585	CcSEcCtD
Almotriptan—Pruritus—Brinzolamide—glaucoma	0.000196	0.000585	CcSEcCtD
Almotriptan—Vomiting—Acetazolamide—glaucoma	0.000195	0.000583	CcSEcCtD
Almotriptan—Dizziness—Brimonidine—glaucoma	0.000195	0.000582	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Clonidine—glaucoma	0.000194	0.000578	CcSEcCtD
Almotriptan—Myalgia—Betaxolol—glaucoma	0.000193	0.000576	CcSEcCtD
Almotriptan—Arthralgia—Betaxolol—glaucoma	0.000193	0.000576	CcSEcCtD
Almotriptan—Chest pain—Betaxolol—glaucoma	0.000193	0.000576	CcSEcCtD
Almotriptan—Diarrhoea—Dorzolamide—glaucoma	0.000193	0.000575	CcSEcCtD
Almotriptan—Headache—Acetazolamide—glaucoma	0.000192	0.000575	CcSEcCtD
Almotriptan—Anxiety—Betaxolol—glaucoma	0.000192	0.000574	CcSEcCtD
Almotriptan—Insomnia—Clonidine—glaucoma	0.000192	0.000574	CcSEcCtD
Almotriptan—Immune system disorder—Timolol—glaucoma	0.000192	0.000574	CcSEcCtD
Almotriptan—Diarrhoea—Travoprost—glaucoma	0.000192	0.000573	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000192	0.000572	CcSEcCtD
Almotriptan—Asthenia—Pilocarpine—glaucoma	0.000191	0.00057	CcSEcCtD
Almotriptan—Paraesthesia—Clonidine—glaucoma	0.000191	0.00057	CcSEcCtD
Almotriptan—Discomfort—Betaxolol—glaucoma	0.000191	0.000569	CcSEcCtD
Almotriptan—Dyspnoea—Clonidine—glaucoma	0.000189	0.000566	CcSEcCtD
Almotriptan—Diarrhoea—Brinzolamide—glaucoma	0.000189	0.000565	CcSEcCtD
Almotriptan—Somnolence—Clonidine—glaucoma	0.000189	0.000564	CcSEcCtD
Almotriptan—Dry mouth—Betaxolol—glaucoma	0.000189	0.000563	CcSEcCtD
Almotriptan—Pruritus—Pilocarpine—glaucoma	0.000188	0.000562	CcSEcCtD
Almotriptan—Confusional state—Betaxolol—glaucoma	0.000187	0.000557	CcSEcCtD
Almotriptan—Mental disorder—Timolol—glaucoma	0.000186	0.000556	CcSEcCtD
Almotriptan—Dizziness—Dorzolamide—glaucoma	0.000186	0.000556	CcSEcCtD
Almotriptan—Rash—Brimonidine—glaucoma	0.000186	0.000555	CcSEcCtD
Almotriptan—Dermatitis—Brimonidine—glaucoma	0.000186	0.000554	CcSEcCtD
Almotriptan—Dizziness—Travoprost—glaucoma	0.000185	0.000553	CcSEcCtD
Almotriptan—Erythema—Timolol—glaucoma	0.000185	0.000553	CcSEcCtD
Almotriptan—Headache—Brimonidine—glaucoma	0.000185	0.000551	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Clonidine—glaucoma	0.000183	0.000548	CcSEcCtD
Almotriptan—Fatigue—Clonidine—glaucoma	0.000183	0.000547	CcSEcCtD
Almotriptan—Dizziness—Brinzolamide—glaucoma	0.000183	0.000546	CcSEcCtD
Almotriptan—Nausea—Acetazolamide—glaucoma	0.000183	0.000545	CcSEcCtD
Almotriptan—Diarrhoea—Pilocarpine—glaucoma	0.000182	0.000543	CcSEcCtD
Almotriptan—Shock—Betaxolol—glaucoma	0.000182	0.000543	CcSEcCtD
Almotriptan—Tension—Timolol—glaucoma	0.000182	0.000542	CcSEcCtD
Almotriptan—Pain—Clonidine—glaucoma	0.000182	0.000542	CcSEcCtD
Almotriptan—Nervous system disorder—Betaxolol—glaucoma	0.000181	0.000542	CcSEcCtD
Almotriptan—Dysgeusia—Timolol—glaucoma	0.000181	0.000541	CcSEcCtD
Almotriptan—Tachycardia—Betaxolol—glaucoma	0.000181	0.000539	CcSEcCtD
Almotriptan—Nervousness—Timolol—glaucoma	0.00018	0.000537	CcSEcCtD
Almotriptan—Skin disorder—Betaxolol—glaucoma	0.00018	0.000536	CcSEcCtD
Almotriptan—Vomiting—Dorzolamide—glaucoma	0.000179	0.000534	CcSEcCtD
Almotriptan—Hyperhidrosis—Betaxolol—glaucoma	0.000179	0.000534	CcSEcCtD
Almotriptan—Rash—Dorzolamide—glaucoma	0.000178	0.00053	CcSEcCtD
Almotriptan—Dermatitis—Dorzolamide—glaucoma	0.000177	0.00053	CcSEcCtD
Almotriptan—Rash—Travoprost—glaucoma	0.000177	0.000528	CcSEcCtD
Almotriptan—Dermatitis—Travoprost—glaucoma	0.000177	0.000527	CcSEcCtD
Almotriptan—Headache—Dorzolamide—glaucoma	0.000176	0.000527	CcSEcCtD
Almotriptan—Vomiting—Brinzolamide—glaucoma	0.000176	0.000525	CcSEcCtD
Almotriptan—Dizziness—Pilocarpine—glaucoma	0.000176	0.000525	CcSEcCtD
Almotriptan—Headache—Travoprost—glaucoma	0.000176	0.000524	CcSEcCtD
Almotriptan—Nausea—Brimonidine—glaucoma	0.000175	0.000523	CcSEcCtD
Almotriptan—Feeling abnormal—Clonidine—glaucoma	0.000175	0.000523	CcSEcCtD
Almotriptan—Rash—Brinzolamide—glaucoma	0.000175	0.000521	CcSEcCtD
Almotriptan—Vision blurred—Timolol—glaucoma	0.000175	0.000521	CcSEcCtD
Almotriptan—Dermatitis—Brinzolamide—glaucoma	0.000174	0.000521	CcSEcCtD
Almotriptan—Gastrointestinal pain—Clonidine—glaucoma	0.000174	0.000519	CcSEcCtD
Almotriptan—Headache—Brinzolamide—glaucoma	0.000173	0.000518	CcSEcCtD
Almotriptan—Angioedema—Timolol—glaucoma	0.000169	0.000505	CcSEcCtD
Almotriptan—Vomiting—Pilocarpine—glaucoma	0.000169	0.000505	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000169	0.000503	CcSEcCtD
Almotriptan—Abdominal pain—Clonidine—glaucoma	0.000168	0.000501	CcSEcCtD
Almotriptan—Body temperature increased—Clonidine—glaucoma	0.000168	0.000501	CcSEcCtD
Almotriptan—Rash—Pilocarpine—glaucoma	0.000168	0.000501	CcSEcCtD
Almotriptan—Dermatitis—Pilocarpine—glaucoma	0.000168	0.0005	CcSEcCtD
Almotriptan—Insomnia—Betaxolol—glaucoma	0.000167	0.000499	CcSEcCtD
Almotriptan—Nausea—Dorzolamide—glaucoma	0.000167	0.000499	CcSEcCtD
Almotriptan—Headache—Pilocarpine—glaucoma	0.000167	0.000498	CcSEcCtD
Almotriptan—Nausea—Travoprost—glaucoma	0.000167	0.000497	CcSEcCtD
Almotriptan—Vertigo—Timolol—glaucoma	0.000166	0.000497	CcSEcCtD
Almotriptan—Paraesthesia—Betaxolol—glaucoma	0.000166	0.000496	CcSEcCtD
Almotriptan—Syncope—Timolol—glaucoma	0.000166	0.000496	CcSEcCtD
Almotriptan—Dyspnoea—Betaxolol—glaucoma	0.000165	0.000492	CcSEcCtD
Almotriptan—Nausea—Brinzolamide—glaucoma	0.000164	0.000491	CcSEcCtD
Almotriptan—Palpitations—Timolol—glaucoma	0.000164	0.000489	CcSEcCtD
Almotriptan—Dyspepsia—Betaxolol—glaucoma	0.000163	0.000486	CcSEcCtD
Almotriptan—Loss of consciousness—Timolol—glaucoma	0.000163	0.000486	CcSEcCtD
Almotriptan—Hypertension—Timolol—glaucoma	0.00016	0.000477	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Betaxolol—glaucoma	0.00016	0.000477	CcSEcCtD
Almotriptan—Fatigue—Betaxolol—glaucoma	0.00016	0.000476	CcSEcCtD
Almotriptan—Pain—Betaxolol—glaucoma	0.000158	0.000472	CcSEcCtD
Almotriptan—Nausea—Pilocarpine—glaucoma	0.000158	0.000472	CcSEcCtD
Almotriptan—Myalgia—Timolol—glaucoma	0.000158	0.000471	CcSEcCtD
Almotriptan—Arthralgia—Timolol—glaucoma	0.000158	0.000471	CcSEcCtD
Almotriptan—Chest pain—Timolol—glaucoma	0.000158	0.000471	CcSEcCtD
Almotriptan—Anxiety—Timolol—glaucoma	0.000157	0.000469	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000157	0.000467	CcSEcCtD
Almotriptan—Hypersensitivity—Clonidine—glaucoma	0.000157	0.000467	CcSEcCtD
Almotriptan—Discomfort—Timolol—glaucoma	0.000156	0.000465	CcSEcCtD
Almotriptan—Dry mouth—Timolol—glaucoma	0.000154	0.00046	CcSEcCtD
Almotriptan—Asthenia—Clonidine—glaucoma	0.000152	0.000455	CcSEcCtD
Almotriptan—Feeling abnormal—Betaxolol—glaucoma	0.000152	0.000455	CcSEcCtD
Almotriptan—Confusional state—Timolol—glaucoma	0.000152	0.000455	CcSEcCtD
Almotriptan—Anaphylactic shock—Timolol—glaucoma	0.000151	0.000451	CcSEcCtD
Almotriptan—Pruritus—Clonidine—glaucoma	0.00015	0.000449	CcSEcCtD
Almotriptan—Shock—Timolol—glaucoma	0.000149	0.000444	CcSEcCtD
Almotriptan—Nervous system disorder—Timolol—glaucoma	0.000148	0.000442	CcSEcCtD
Almotriptan—Skin disorder—Timolol—glaucoma	0.000147	0.000438	CcSEcCtD
Almotriptan—Body temperature increased—Betaxolol—glaucoma	0.000146	0.000437	CcSEcCtD
Almotriptan—Hyperhidrosis—Timolol—glaucoma	0.000146	0.000436	CcSEcCtD
Almotriptan—Diarrhoea—Clonidine—glaucoma	0.000145	0.000434	CcSEcCtD
Almotriptan—Dizziness—Clonidine—glaucoma	0.000141	0.000419	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Timolol—glaucoma	0.000138	0.000411	CcSEcCtD
Almotriptan—Insomnia—Timolol—glaucoma	0.000137	0.000408	CcSEcCtD
Almotriptan—Hypersensitivity—Betaxolol—glaucoma	0.000136	0.000407	CcSEcCtD
Almotriptan—Paraesthesia—Timolol—glaucoma	0.000136	0.000405	CcSEcCtD
Almotriptan—Vomiting—Clonidine—glaucoma	0.000135	0.000403	CcSEcCtD
Almotriptan—Dyspnoea—Timolol—glaucoma	0.000135	0.000402	CcSEcCtD
Almotriptan—Somnolence—Timolol—glaucoma	0.000134	0.000401	CcSEcCtD
Almotriptan—Rash—Clonidine—glaucoma	0.000134	0.0004	CcSEcCtD
Almotriptan—Dermatitis—Clonidine—glaucoma	0.000134	0.0004	CcSEcCtD
Almotriptan—Headache—Clonidine—glaucoma	0.000133	0.000397	CcSEcCtD
Almotriptan—Dyspepsia—Timolol—glaucoma	0.000133	0.000397	CcSEcCtD
Almotriptan—Asthenia—Betaxolol—glaucoma	0.000133	0.000396	CcSEcCtD
Almotriptan—Pruritus—Betaxolol—glaucoma	0.000131	0.000391	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Timolol—glaucoma	0.00013	0.000389	CcSEcCtD
Almotriptan—Fatigue—Timolol—glaucoma	0.00013	0.000389	CcSEcCtD
Almotriptan—Pain—Timolol—glaucoma	0.000129	0.000386	CcSEcCtD
Almotriptan—Diarrhoea—Betaxolol—glaucoma	0.000127	0.000378	CcSEcCtD
Almotriptan—Nausea—Clonidine—glaucoma	0.000126	0.000377	CcSEcCtD
Almotriptan—Feeling abnormal—Timolol—glaucoma	0.000125	0.000372	CcSEcCtD
Almotriptan—Gastrointestinal pain—Timolol—glaucoma	0.000124	0.000369	CcSEcCtD
Almotriptan—Dizziness—Betaxolol—glaucoma	0.000122	0.000365	CcSEcCtD
Almotriptan—Abdominal pain—Timolol—glaucoma	0.000119	0.000357	CcSEcCtD
Almotriptan—Body temperature increased—Timolol—glaucoma	0.000119	0.000357	CcSEcCtD
Almotriptan—Vomiting—Betaxolol—glaucoma	0.000118	0.000351	CcSEcCtD
Almotriptan—Rash—Betaxolol—glaucoma	0.000117	0.000348	CcSEcCtD
Almotriptan—Dermatitis—Betaxolol—glaucoma	0.000117	0.000348	CcSEcCtD
Almotriptan—Headache—Betaxolol—glaucoma	0.000116	0.000346	CcSEcCtD
Almotriptan—Hypersensitivity—Timolol—glaucoma	0.000111	0.000332	CcSEcCtD
Almotriptan—Nausea—Betaxolol—glaucoma	0.00011	0.000328	CcSEcCtD
Almotriptan—Asthenia—Timolol—glaucoma	0.000108	0.000324	CcSEcCtD
Almotriptan—Pruritus—Timolol—glaucoma	0.000107	0.000319	CcSEcCtD
Almotriptan—Diarrhoea—Timolol—glaucoma	0.000103	0.000309	CcSEcCtD
Almotriptan—Dizziness—Timolol—glaucoma	0.0001	0.000298	CcSEcCtD
Almotriptan—Vomiting—Timolol—glaucoma	9.61e-05	0.000287	CcSEcCtD
Almotriptan—Rash—Timolol—glaucoma	9.53e-05	0.000284	CcSEcCtD
Almotriptan—Dermatitis—Timolol—glaucoma	9.52e-05	0.000284	CcSEcCtD
Almotriptan—Headache—Timolol—glaucoma	9.47e-05	0.000283	CcSEcCtD
Almotriptan—HTR1B—GPCR downstream signaling—PTGFR—glaucoma	9.25e-05	0.00225	CbGpPWpGaD
Almotriptan—Nausea—Timolol—glaucoma	8.98e-05	0.000268	CcSEcCtD
Almotriptan—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	8.88e-05	0.00216	CbGpPWpGaD
Almotriptan—FMO3—SIDS Susceptibility Pathways—TNF—glaucoma	8.8e-05	0.00214	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—PTGFR—glaucoma	8.58e-05	0.00209	CbGpPWpGaD
Almotriptan—CYP2C8—Biological oxidations—GSTT1—glaucoma	8.51e-05	0.00207	CbGpPWpGaD
Almotriptan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	8.45e-05	0.00206	CbGpPWpGaD
Almotriptan—HTR1D—GPCR ligand binding—SMO—glaucoma	8.43e-05	0.00205	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—PTGFR—glaucoma	8.4e-05	0.00205	CbGpPWpGaD
Almotriptan—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	8.34e-05	0.00203	CbGpPWpGaD
Almotriptan—HTR1B—GPCR ligand binding—SMO—glaucoma	8.26e-05	0.00201	CbGpPWpGaD
Almotriptan—CYP2C8—Arachidonic acid metabolism—PTGS2—glaucoma	8.21e-05	0.002	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—LRP12—glaucoma	8.12e-05	0.00198	CbGpPWpGaD
Almotriptan—HTR1D—G alpha (i) signalling events—C3—glaucoma	8.02e-05	0.00195	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—LRP12—glaucoma	7.95e-05	0.00194	CbGpPWpGaD
Almotriptan—HTR1B—G alpha (i) signalling events—C3—glaucoma	7.85e-05	0.00191	CbGpPWpGaD
Almotriptan—CYP2E1—Biological oxidations—CYP1B1—glaucoma	7.85e-05	0.00191	CbGpPWpGaD
Almotriptan—CYP2E1—Metapathway biotransformation—CYP1B1—glaucoma	7.74e-05	0.00188	CbGpPWpGaD
Almotriptan—CYP2C19—Biological oxidations—GSTT1—glaucoma	7.6e-05	0.00185	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—TXN—glaucoma	7.41e-05	0.0018	CbGpPWpGaD
Almotriptan—CYP2C19—Arachidonic acid metabolism—PTGS2—glaucoma	7.33e-05	0.00179	CbGpPWpGaD
Almotriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	7.3e-05	0.00178	CbGpPWpGaD
Almotriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	7.15e-05	0.00174	CbGpPWpGaD
Almotriptan—CYP2D6—Biological oxidations—GSTT1—glaucoma	6.99e-05	0.0017	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CA5A—glaucoma	6.9e-05	0.00168	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—NARFL—glaucoma	6.9e-05	0.00168	CbGpPWpGaD
Almotriptan—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	6.85e-05	0.00167	CbGpPWpGaD
Almotriptan—CYP2C8—Biological oxidations—CYP1B1—glaucoma	6.78e-05	0.00165	CbGpPWpGaD
Almotriptan—CYP2C8—Metapathway biotransformation—CYP1B1—glaucoma	6.69e-05	0.00163	CbGpPWpGaD
Almotriptan—CYP1A2—Phase II conjugation—GSTM1—glaucoma	6.45e-05	0.00157	CbGpPWpGaD
Almotriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	6.38e-05	0.00155	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—CTSA—glaucoma	6.34e-05	0.00154	CbGpPWpGaD
Almotriptan—CYP2E1—Biological oxidations—GSTM1—glaucoma	6.27e-05	0.00153	CbGpPWpGaD
Almotriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	6.25e-05	0.00152	CbGpPWpGaD
Almotriptan—CYP2E1—Metapathway biotransformation—GSTM1—glaucoma	6.19e-05	0.00151	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	6.11e-05	0.00149	CbGpPWpGaD
Almotriptan—CYP2C19—Biological oxidations—CYP1B1—glaucoma	6.05e-05	0.00147	CbGpPWpGaD
Almotriptan—CYP2C19—Metapathway biotransformation—CYP1B1—glaucoma	5.97e-05	0.00145	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CA5A—glaucoma	5.97e-05	0.00145	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—NARFL—glaucoma	5.97e-05	0.00145	CbGpPWpGaD
Almotriptan—CYP1A2—Biological oxidations—GSTT1—glaucoma	5.92e-05	0.00144	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	5.78e-05	0.00141	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	5.78e-05	0.00141	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—GSTT1—glaucoma	5.74e-05	0.0014	CbGpPWpGaD
Almotriptan—CYP1A2—Arachidonic acid metabolism—PTGS2—glaucoma	5.71e-05	0.00139	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—CTSA—glaucoma	5.65e-05	0.00138	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—OPN4—glaucoma	5.63e-05	0.00137	CbGpPWpGaD
Almotriptan—CYP2D6—Biological oxidations—CYP1B1—glaucoma	5.57e-05	0.00136	CbGpPWpGaD
Almotriptan—HTR1D—GPCR ligand binding—EDN1—glaucoma	5.56e-05	0.00135	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—OPN4—glaucoma	5.51e-05	0.00134	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—CA1—glaucoma	5.49e-05	0.00134	CbGpPWpGaD
Almotriptan—CYP2D6—Metapathway biotransformation—CYP1B1—glaucoma	5.49e-05	0.00134	CbGpPWpGaD
Almotriptan—HTR1B—GPCR ligand binding—EDN1—glaucoma	5.44e-05	0.00133	CbGpPWpGaD
Almotriptan—CYP2C8—Biological oxidations—GSTM1—glaucoma	5.42e-05	0.00132	CbGpPWpGaD
Almotriptan—CYP2C8—Metapathway biotransformation—GSTM1—glaucoma	5.35e-05	0.0013	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—NARFL—glaucoma	5.32e-05	0.0013	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CA5A—glaucoma	5.32e-05	0.0013	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—CTSA—glaucoma	5.32e-05	0.0013	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—HEYL—glaucoma	5.23e-05	0.00127	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—HEYL—glaucoma	5.13e-05	0.00125	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PTGFR—glaucoma	5.07e-05	0.00123	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—CA2—glaucoma	5.02e-05	0.00122	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PTGFR—glaucoma	4.96e-05	0.00121	CbGpPWpGaD
Almotriptan—MAOA—SIDS Susceptibility Pathways—VEGFA—glaucoma	4.91e-05	0.0012	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CA5A—glaucoma	4.9e-05	0.00119	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—NARFL—glaucoma	4.9e-05	0.00119	CbGpPWpGaD
Almotriptan—HTR1D—GPCR ligand binding—C3—glaucoma	4.86e-05	0.00118	CbGpPWpGaD
Almotriptan—CYP2C19—Biological oxidations—GSTM1—glaucoma	4.84e-05	0.00118	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	4.81e-05	0.00117	CbGpPWpGaD
Almotriptan—CYP2C19—Metapathway biotransformation—GSTM1—glaucoma	4.77e-05	0.00116	CbGpPWpGaD
Almotriptan—HTR1B—GPCR ligand binding—C3—glaucoma	4.76e-05	0.00116	CbGpPWpGaD
Almotriptan—CYP1A2—Biological oxidations—CYP1B1—glaucoma	4.72e-05	0.00115	CbGpPWpGaD
Almotriptan—CYP1A2—Metapathway biotransformation—CYP1B1—glaucoma	4.65e-05	0.00113	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—ABCA1—glaucoma	4.58e-05	0.00111	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—CYP1B1—glaucoma	4.58e-05	0.00111	CbGpPWpGaD
Almotriptan—CYP3A4—Biological oxidations—GSTT1—glaucoma	4.57e-05	0.00111	CbGpPWpGaD
Almotriptan—CYP2D6—Biological oxidations—GSTM1—glaucoma	4.45e-05	0.00108	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	4.41e-05	0.00107	CbGpPWpGaD
Almotriptan—CYP2D6—Metapathway biotransformation—GSTM1—glaucoma	4.39e-05	0.00107	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—SMO—glaucoma	4.33e-05	0.00105	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—SMO—glaucoma	4.24e-05	0.00103	CbGpPWpGaD
Almotriptan—MAOA—SIDS Susceptibility Pathways—TNF—glaucoma	4.21e-05	0.00102	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—NARFL—glaucoma	4.15e-05	0.00101	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CA5A—glaucoma	4.15e-05	0.00101	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	4.12e-05	0.001	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor—TNF—glaucoma	4.12e-05	0.001	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—RPTOR—glaucoma	3.97e-05	0.000966	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—RPTOR—glaucoma	3.88e-05	0.000946	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—NCK2—glaucoma	3.84e-05	0.000936	CbGpPWpGaD
Almotriptan—CYP1A2—Biological oxidations—GSTM1—glaucoma	3.77e-05	0.000918	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—NCK2—glaucoma	3.76e-05	0.000916	CbGpPWpGaD
Almotriptan—CYP1A2—Metapathway biotransformation—GSTM1—glaucoma	3.72e-05	0.000906	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—GSTM1—glaucoma	3.66e-05	0.000891	CbGpPWpGaD
Almotriptan—CYP3A4—Biological oxidations—CYP1B1—glaucoma	3.64e-05	0.000887	CbGpPWpGaD
Almotriptan—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	3.59e-05	0.000874	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—TXN—glaucoma	3.54e-05	0.000862	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CA1—glaucoma	3.37e-05	0.000821	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—HDAC9—glaucoma	3.27e-05	0.000796	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CTSA—glaucoma	3.26e-05	0.000795	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—MTHFR—glaucoma	3.23e-05	0.000787	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CA5A—glaucoma	3.2e-05	0.00078	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—NARFL—glaucoma	3.2e-05	0.00078	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—HDAC9—glaucoma	3.2e-05	0.000779	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—EDN1—glaucoma	3.14e-05	0.000765	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CA2—glaucoma	3.08e-05	0.000751	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—EDN1—glaucoma	3.08e-05	0.000749	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—APOE—glaucoma	3.01e-05	0.000733	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—CAV1—glaucoma	2.98e-05	0.000726	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CA1—glaucoma	2.91e-05	0.00071	CbGpPWpGaD
Almotriptan—CYP3A4—Biological oxidations—GSTM1—glaucoma	2.91e-05	0.000709	CbGpPWpGaD
Almotriptan—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	2.87e-05	0.000699	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—EDN1—glaucoma	2.85e-05	0.000695	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CTSA—glaucoma	2.82e-05	0.000687	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—EDN1—glaucoma	2.79e-05	0.00068	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—GSTT1—glaucoma	2.74e-05	0.000669	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—C3—glaucoma	2.74e-05	0.000668	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—C3—glaucoma	2.69e-05	0.000655	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CA2—glaucoma	2.66e-05	0.000649	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.6e-05	0.000634	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.6e-05	0.000634	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CA1—glaucoma	2.6e-05	0.000633	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—SMO—glaucoma	2.56e-05	0.000623	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CTSA—glaucoma	2.52e-05	0.000613	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—SMO—glaucoma	2.5e-05	0.00061	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—C3—glaucoma	2.49e-05	0.000607	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—C3—glaucoma	2.44e-05	0.000594	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CA1—glaucoma	2.39e-05	0.000582	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CA2—glaucoma	2.38e-05	0.000579	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—NTRK2—glaucoma	2.34e-05	0.000569	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.32e-05	0.000566	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.32e-05	0.000566	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CTSA—glaucoma	2.32e-05	0.000564	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—NTRK2—glaucoma	2.29e-05	0.000558	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—NOS3—glaucoma	2.25e-05	0.000549	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CA2—glaucoma	2.19e-05	0.000533	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—ABCA1—glaucoma	2.19e-05	0.000533	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—CYP1B1—glaucoma	2.19e-05	0.000533	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—TXN—glaucoma	2.17e-05	0.000529	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—PTGS2—glaucoma	2.06e-05	0.000502	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CA1—glaucoma	2.03e-05	0.000493	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—NGFR—glaucoma	2.01e-05	0.000489	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—NGFR—glaucoma	1.96e-05	0.000478	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CTSA—glaucoma	1.96e-05	0.000478	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—NTRK1—glaucoma	1.91e-05	0.000464	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—TXN—glaucoma	1.88e-05	0.000457	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—NTRK1—glaucoma	1.87e-05	0.000455	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CA2—glaucoma	1.85e-05	0.000451	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.81e-05	0.000441	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.81e-05	0.000441	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CDKN2B—glaucoma	1.76e-05	0.000428	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—GSTM1—glaucoma	1.75e-05	0.000426	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CDKN2B—glaucoma	1.72e-05	0.000419	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.71e-05	0.000417	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.7e-05	0.000413	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—EDN1—glaucoma	1.69e-05	0.000411	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—GSTT1—glaucoma	1.68e-05	0.00041	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—TXN—glaucoma	1.68e-05	0.000408	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—EDN1—glaucoma	1.65e-05	0.000402	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CA1—glaucoma	1.56e-05	0.000381	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—NGF—glaucoma	1.55e-05	0.000377	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—MTHFR—glaucoma	1.55e-05	0.000376	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—TXN—glaucoma	1.54e-05	0.000375	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.53e-05	0.000372	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—NGF—glaucoma	1.52e-05	0.000369	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.51e-05	0.000369	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CTSA—glaucoma	1.51e-05	0.000369	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—C3—glaucoma	1.47e-05	0.000359	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GSTT1—glaucoma	1.46e-05	0.000355	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—C3—glaucoma	1.44e-05	0.000351	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—APOE—glaucoma	1.44e-05	0.00035	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CA2—glaucoma	1.43e-05	0.000348	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—CAV1—glaucoma	1.43e-05	0.000347	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—APOE—glaucoma	1.37e-05	0.000334	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CAV1—glaucoma	1.36e-05	0.000331	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—APOE—glaucoma	1.34e-05	0.000327	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—ABCA1—glaucoma	1.34e-05	0.000327	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CYP1B1—glaucoma	1.34e-05	0.000327	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CAV1—glaucoma	1.33e-05	0.000324	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—TXN—glaucoma	1.31e-05	0.000318	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GSTT1—glaucoma	1.3e-05	0.000316	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—FN1—glaucoma	1.29e-05	0.000315	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—BAD—glaucoma	1.28e-05	0.000311	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—FN1—glaucoma	1.27e-05	0.000308	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—BAD—glaucoma	1.25e-05	0.000305	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GSTT1—glaucoma	1.19e-05	0.000291	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.19e-05	0.00029	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.18e-05	0.000287	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.17e-05	0.000286	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—ABCA1—glaucoma	1.16e-05	0.000282	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CYP1B1—glaucoma	1.16e-05	0.000282	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—NOS3—glaucoma	1.08e-05	0.000262	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—GSTM1—glaucoma	1.07e-05	0.000261	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.05e-05	0.000255	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—ABCA1—glaucoma	1.04e-05	0.000252	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CYP1B1—glaucoma	1.04e-05	0.000252	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—NOS3—glaucoma	1.03e-05	0.00025	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GSTT1—glaucoma	1.01e-05	0.000247	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—TXN—glaucoma	1.01e-05	0.000245	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—NOS3—glaucoma	1.01e-05	0.000245	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PTGS2—glaucoma	9.86e-06	0.00024	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ABCA1—glaucoma	9.52e-06	0.000232	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CYP1B1—glaucoma	9.52e-06	0.000232	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—MTHFR—glaucoma	9.48e-06	0.000231	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GSTM1—glaucoma	9.27e-06	0.000226	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CDKN1B—glaucoma	8.9e-06	0.000217	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—APOE—glaucoma	8.83e-06	0.000215	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CAV1—glaucoma	8.74e-06	0.000213	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CDKN1B—glaucoma	8.71e-06	0.000212	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GSTM1—glaucoma	8.28e-06	0.000202	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MMP9—glaucoma	8.24e-06	0.000201	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—MTHFR—glaucoma	8.19e-06	0.0002	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	8.16e-06	0.000199	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MMP9—glaucoma	8.07e-06	0.000196	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CYP1B1—glaucoma	8.07e-06	0.000196	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ABCA1—glaucoma	8.07e-06	0.000196	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GSTT1—glaucoma	7.81e-06	0.00019	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—APOE—glaucoma	7.63e-06	0.000186	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GSTM1—glaucoma	7.61e-06	0.000185	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CAV1—glaucoma	7.56e-06	0.000184	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—VEGFA—glaucoma	7.4e-06	0.00018	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—MTHFR—glaucoma	7.31e-06	0.000178	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—VEGFA—glaucoma	7.24e-06	0.000176	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—APOE—glaucoma	6.81e-06	0.000166	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CAV1—glaucoma	6.75e-06	0.000164	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—MTHFR—glaucoma	6.73e-06	0.000164	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—NOS3—glaucoma	6.61e-06	0.000161	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GSTM1—glaucoma	6.45e-06	0.000157	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—APOE—glaucoma	6.26e-06	0.000153	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ABCA1—glaucoma	6.22e-06	0.000152	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYP1B1—glaucoma	6.22e-06	0.000152	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CAV1—glaucoma	6.2e-06	0.000151	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PTGS2—glaucoma	6.05e-06	0.000147	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—NOS3—glaucoma	5.71e-06	0.000139	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—MTHFR—glaucoma	5.7e-06	0.000139	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—TP53—glaucoma	5.59e-06	0.000136	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—TP53—glaucoma	5.47e-06	0.000133	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—APOE—glaucoma	5.31e-06	0.000129	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CAV1—glaucoma	5.26e-06	0.000128	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PTGS2—glaucoma	5.23e-06	0.000127	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—NOS3—glaucoma	5.1e-06	0.000124	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GSTM1—glaucoma	4.98e-06	0.000121	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—NOS3—glaucoma	4.69e-06	0.000114	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PTGS2—glaucoma	4.67e-06	0.000114	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—MTHFR—glaucoma	4.4e-06	0.000107	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PTGS2—glaucoma	4.29e-06	0.000105	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—APOE—glaucoma	4.09e-06	9.97e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CAV1—glaucoma	4.06e-06	9.88e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—NOS3—glaucoma	3.97e-06	9.68e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PTGS2—glaucoma	3.64e-06	8.85e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—NOS3—glaucoma	3.07e-06	7.47e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PTGS2—glaucoma	2.81e-06	6.83e-05	CbGpPWpGaD
